Diaverum develops breakthrough AI model to deliver step-change in Vascular Access thrombosis prevention
Diaverum, a leading global renal care service provider, has developed an artificial intelligence model to support the company’s physicians and nurses predict with a high degree of accuracy, episodes of vascular access thrombosis among haemodialysed patients. Simulations using Diaverum’s historical patient data predicted an average of 75% of actual cases that were not detected by best-in-class clinical assessments and monitoring systems.Vascular Access (VA) thrombosis is a major factor of suffering and increased mortality for chronic haemodialysis patients, with incidence ranging between 0.